Published June 15, 2019 | Version v1
Journal article

Radiogenomics in renal cell carcinoma

  • 1. Harvard Medical School, Department of Imaging, Dana-Farber Cancer Institute (United States)
  • 2. Dana-Farber Cancer Institute, Lank Center for Genitourinary Oncology (United States)

Description

Radiogenomics, a field of radiology investigating the association between the imaging features of a disease and its gene expression pattern, has expanded considerably in the last few years. Recent advances in whole-genome sequencing of clear cell renal cell carcinoma (ccRCC) and the identification of mutations with prognostic significance have led to increased interest in the relationship between imaging and genomic data. ccRCC is particularly suitable for radiogenomic analysis as the relative paucity of mutated genes allows for more straightforward genomic-imaging associations. The ultimate aim of radiogenomics of ccRCC is to retrieve additional data for accurate diagnosis, prognostic stratification, and optimization of therapy. In this review article, we will present the state-of-the-art of radiogenomics of ccRCC, and after briefly reviewing updates in genomics, we will discuss imaging-genomic associations for diagnosis and staging, prognosis, and for assessment of optimal therapy in ccRCC.

Additional details

Identifiers

Publishing Information

Journal Title
Abdominal Radiology (Online)
Journal Volume
44
Journal Issue
6
Journal Page Range
p. 1990-1998
ISSN
2366-0058

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51086828
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; KIDNEYS; NMR IMAGING; RADIOLOGY; THERAPY
Descriptors DEC
BODY; DIAGNOSTIC TECHNIQUES; DISEASES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; TOMOGRAPHY

Optional Information

Copyright
Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature